Accurate outcome prediction after neo-adjuvant radio-chemotherapy for rectal cancer based on a TCP-based early regression index

Smith, 2015, Advances and challenges in treatment of locally advanced rectal cancer, J Clin Oncol, 33, 1797, 10.1200/JCO.2014.60.1054 Rödel, 2016, Rectal cancer: neoadjuvant chemoradiotherapy, Best Pract Res Clin Gastroenterol, 30, 629, 10.1016/j.bpg.2016.06.004 Ryan, 2016, Predicting pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a systematic review, Colorectal Dis, 18, 234, 10.1111/codi.13207 Huh, 2013, Clinical prediction of pathological complete response after preoperative chemoradiotherapy for rectal cancer, Dis Colon and Rectum, 56, 698, 10.1097/DCR.0b013e3182837e5b Taylor, 2014, Preoperative magnetic resonance imaging assessment of circumferential resection margin predicts disease-free survival and local recurrence: 5-year follow-up results of the MERCURY Study, J Clin Oncol, 32, 34, 10.1200/JCO.2012.45.3258 Van Stiphout, 2011, Development and external validation of a predictive model for pathological complete response of rectal cancer patients including sequential PET-CT imaging, Radiother Oncol, 98, 126, 10.1016/j.radonc.2010.12.002 Bulens, 2018, Development and validation of an MRI-based model to predict response to chemoradiotherapy for rectal cancer, Radiother Oncol, 126, 437, 10.1016/j.radonc.2018.01.008 Jia, 2018, Predicting the pathological response to neoadjuvant chemoradiation using untargeted metabolomics in locally advanced rectal cancer, Radiother Oncol, 128, 548, 10.1016/j.radonc.2018.06.022 Molinari, 2015, Biomarkers and molecular imaging as predictors of response to neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer, Clin Colorect Cancer, 14, 227, 10.1016/j.clcc.2015.05.014 Rödel, 2005, Prognostic significance of tumor regression after radiochemotherapy of rectal cancer, J Cllin Oncol, 23, 8688, 10.1200/JCO.2005.02.1329 Patel, 2011, Magnetic resonance imaging-detected tumor response for locally advanced rectal cancer predicts survival outcomes: MERCURY experience, J Clin Oncol, 29, 3753, 10.1200/JCO.2011.34.9068 Beets-Tan, 2014, MRI for assessing and predicting response to neoadjuvant treatment in rectal cancer, Nat. Rev. Gastroenterol. Hepatol., 11, 480, 10.1038/nrgastro.2014.41 Barbaro, 2009, Locally advanced rectal cancer: MR imaging in prediction of response after preoperative chemotherapy and radiation therapy, Radiology, 250, 730, 10.1148/radiol.2503080310 Curvo-Semedo, 2011, Rectal cancer assessment of complete response to preoperative combined radiation therapy with chemotherapy: conventional MR volumetry vs diffusion-weighted MR imaging, Radiology, 260, 734, 10.1148/radiol.11102467 Patel, 2012, Comparison of magnetic resonance imaging and histopathological response to chemoradiotherapy in locally advanced rectal cancer, Annals Surg Oncol, 19, 2842, 10.1245/s10434-012-2309-3 Intven, 2015, Combined T2w volumetry, DW-MRI and DCE-MRI for response assessment after neo-adjuvant chemoradiation in locally advanced rectal cancer, Acta Oncol, 54, 1729, 10.3109/0284186X.2015.1037010 Joye, 2017, Quantitative imaging outperforms molecular markers when predicting response to radiochemotherapy for rectal cancer, Radiother Oncol, 124, 104, 10.1016/j.radonc.2017.06.013 Palmisano, 2018, Could early tumor volume change assessed on morphological MRI predict the response to Chemoradiation therapy in locally advanced rectal cancer?, Clin Radiol, 73, 555, 10.1016/j.crad.2018.01.007 Fiorino, 2018, A TCP-based early regression index predicts the pathological response in neo-adjuvant radio-chemotherapy of rectal cancer, Radiother Oncol, 128, 564, 10.1016/j.radonc.2018.06.019 Maas, 2011, Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer, J Clin Oncol, 29, 4633, 10.1200/JCO.2011.37.7176 Habr-Gama, 2011, Nonoperative approaches to rectal cancer: a critical evaluation, Sem Radiat Oncol, 21, 234, 10.1016/j.semradonc.2011.02.010 Renehan, 2016, Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis, Lancet Oncol, 17, 174, 10.1016/S1470-2045(15)00467-2 Passoni, 2013, Feasibility of an adaptive strategy in preoperative radiochemotherapy for rectal cancer with image-guided tomotherapy: boosting the dose to the shrinking tumor, Int J Radiat Oncol Biol Phys, 87, 67, 10.1016/j.ijrobp.2013.05.004 Maggiulli, 2012, Characterisation of rectal motion during neo-adjuvant radiochemotherapy for rectal cancer with image-guided tomotherapy: implications for adaptive dose escalation strategies, Acta Oncol, 51, 318, 10.3109/0284186X.2012.666358 Raso, 2015, Assessment and clinical validation of margins for adaptive simultaneous integrated boost in neo-adjuvant radiochemotherapy for rectal cancer, Phys Med, 31, 167, 10.1016/j.ejmp.2014.12.002 Fiorino, 2016, The promise of adaptive radiotherapy for pelvic tumors: “too high cost for too little result” or “a low cost for a significant result”?, Acta Oncol, 55, 939, 10.1080/0284186X.2016.1203460 Appelt, 2015, High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: a prospective observational study, Lancet Oncol, 16, 919, 10.1016/S1470-2045(15)00120-5 Borggreve, 2018, Preoperative image-guided identification of response to neoadjuvant chemoradiotherapy in esophageal cancer (PRIDE): a multicenter observational study, BMC Cancer, 18, 1006, 10.1186/s12885-018-4892-6 Johnson, 1995, The tumor volume and clonogen number relationship: Tumor control predictions based upon tumor volume estimates derived from computed tomography, Int J Radiat Oncol Biol Phys, 33, 281, 10.1016/0360-3016(95)00119-J Chvetsov, 2013, Tumor response parameters for head and neck cancer derived from tumor-volume variation during radiation therapy, Med Phys, 40, 10.1118/1.4789632 DeLong, 1988, Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach, Biometrics, 44, 837, 10.2307/2531595 Rödel, 2015, Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial, Lancet Oncol, 16, 979, 10.1016/S1470-2045(15)00159-X Flatmark, 2013, Effect of oxaliplatin-containing neoadjuvant chemotherapy on tumor volume in locally advanced rectal cancer and sensitivity of surviving tumor cells to radiotherapy, J Clin Oncol, 31, 3547, 10.1200/jco.2013.31.15_suppl.3547 Vanpouille-Box, 2018, Toward precision radiotherapy for use with immune checkpoint blockers, Clin Cancer Res, 24, 259, 10.1158/1078-0432.CCR-16-0037 Ludmir, 2017, Total neoadjuvant therapy for rectal cancer: an emerging option, Cancer, 123, 1497, 10.1002/cncr.30600